If concomitant use with other serotonergic medication or CYP2D6 inhibitors is clinically warranted, initiate therapy with lower doses, keep track of sufferers for emergence of serotonin syndrome all through drug initiation or titration, and inform sufferers of amplified danger for serotonin syndromei Actually doubt my doc may have a prob bc he isn'